Ventio

Deutsch

Vascular dementia

Potential Indications – Vascular dementia Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Vascular dementia is a neurodegenerative disease with multiple aetiologies. Damage to cerebral nervous tissue may be due to ischaemic lesions involving small … Read More

Featured Post

Parkinson disease

Potential Indications – Parkinson disease Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Parkinson’s disease is a neurodegenerative disorder caused by the formation of a-synuclein protein aggregates in neurons and their death. Associated with this … Read More

Featured Post

Alzheimer’s and related diseases

Potential Indications – Alzheimer’s and related diseases Discover a potential indication of advanced technology of magnetic susceptibility. Dr ROCHE Stéphane Alzheimer’s disease is a progressive neurodegenerative disorder affecting various brain regions. The pathophysiological process involves an accumulation of Aβ peptides … Read More

Featured Post

[Context] Iron, iron accumulation and ferroptosis

Potential Indications [Context] Iron, iron accumulation and ferroptosis Dr ROCHE Stéphane Background to our series of articles “Biomedical applications of advanced technology of magnetic susceptibility” Intracerebral iron is involved in the formation and maintenance of neuronal networks and is essential … Read More

Featured Post

How and why implement ISO27001?

How and why implement ISO27001? Committed to a quality approach involving information security management, Ventio has decided to follow the ISO 27001 standard, considered to be the benchmark in this field. Noémie Vang is a certified ‚Lead Implementer‘, enabling the … Read More

Featured Post

Stephane Roche becomes CEO of Ventio

Stephane Roche becomes CEO of Ventio Technical Director for the past 2 years, Dr Stephane Roche took up his new position as Chief Executive Officer of Ventio at the end of April 2024. This appointment recognises the work of a … Read More

Featured Post

[Revue Polytechnique]

Imaging services at the cutting edge of innovation and with very high added value In March 2024 issue, „La Jaune & La Rouge“ magazine interviewed our CEO Ludovic de Rochefort about Ventio’s expertise, the importance of sharing healthcare data to … Read More

Featured Post

Neue Mitarbeiterin bei Ventio soll IT-Systemsicherheit stärken

Neue Mitarbeiterin bei Ventio soll IT-Systemsicherheit stärken Hello Anis, welcome!  You joined the team a few weeks ago already.  In order to get to know you better and understand your missions at Ventio, we invite you to answer a few … Read More

Featured Post

Ventio – our vision

Following its participation in Journées Francophones de Radiologie 2023, Ventio presents its services, vision and ethics. Using biomedical imaging with innovative biomarkers to help identify new therapeutic targets, help diagnose brain diseases, treat patients earlier and improve their follow-up. Ventio … Read More

Featured Post

Genehmigung der französischen Forschungszulage (Crédit d’impôt recherche, CIR). Ventio kann Sie jetzt bei Ihren Forschungsprojekten unterstützen!

Forschungszulagengesetz Genehmigung der französischen Forschungszulage (Crédit d’impôt recherche, CIR). Ventio kann Sie jetzt bei Ihren Forschungsprojekten unterstützen! Es ist offiziell: Ventio wurde als private Forschungs- und Entwicklungsorganisation für den Zeitraum 2022–2024 zertifiziert und sie können von der französischen Forschungszulage (cédit … Read More

Featured Post